Page last updated: 2024-09-02

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Shock, Septic

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Shock, Septic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruetten, H; Thiemermann, C; Vane, JR1

Other Studies

1 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Shock, Septic

ArticleYear
Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.
    British journal of pharmacology, 1996, Volume: 118, Issue:1

    Topics: Acid-Base Equilibrium; Anesthesia; Animals; Blood Gas Analysis; Blood Pressure; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Hemodynamics; Indans; Interferon-gamma; Kidney; Lipopolysaccharides; Liver; Male; Norepinephrine; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Shock, Septic; Tumor Necrosis Factor-alpha

1996